"Fortis Flt. Lt. Rajan Dhall Hospital, Vasant Kunj is a multi-specialty tertiary care hospital, that has played a pivotal role in transforming medical healthcare infrastructure in NCR Region. The hospital has total Seven Center for Excellence for Cardiac Sciences, Orthopedics & Joint Replacement, Renal Sciences, Oncology, Rheumatology, Pulmonology & Critical Care and Bariatric Sciences. With 162 beds and patient centric approach, the hospital aims at providing compassionate patient care with clinical excellence, to achieve a single-minded objective of “Saving and Enriching Lives”."

During the past decade, Fortis Flt. Lt. Rajan Dhall Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fortis Flt. Lt. Rajan Dhall Hospital" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Diabetes Foundation, India" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fortis Flt. Lt. Rajan Dhall Hospital" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator and "TotipotentRX Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Fortis Flt. Lt. Rajan Dhall Hospital" are "Nonalcoholic Steatohepatitis" (2 trials), "Acute Myocardial Infarction" (1 trials), "Bradycardia" (1 trials), "Chronic Kidney Disease" (1 trials) and "Critical Limb Ischemia" (1 trials). Many other conditions were trialed in "Fortis Flt. Lt. Rajan Dhall Hospital" in a lesser frequency.

Most popular intervention types in "Fortis Flt. Lt. Rajan Dhall Hospital" are "Drug" (7 trials), "Other" (2 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials), "SEL" (2 trials), "Autologous Bone marrow mononuclear cells" (1 trials) and "CRT Patients" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fortis Flt. Lt. Rajan Dhall Hospital" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Fortis Flt. Lt. Rajan Dhall Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Fortis Flt. Lt. Rajan Dhall Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fortis Flt. Lt. Rajan Dhall Hospital, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".